Drugs / ACTR707
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03189836 | Oct 2017 → Sep 2020 | lymphoma | Cogent Biosciences, Inc. | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACTR707 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03189836 ↗ |
| Modality | Cell therapy | “autologous T cell product” NCT03189836 ↗ |